6-Cyano analogues of bedaquiline as less lipophilic and potentially safer diarylquinolines for tuberculosis
, NaO t Bu, PhCF 3 , 100 C (800 W), 0.25 h; (l) 102 (X = I, B = Ph), sulfonamide, CuI, K 3 PO 4 , DMF, 100°C (sealed tube), 40 h; (m) 128 (X = NMeSO 2 NHMe), NaH, MeI, MeCN, r.t., 24 h; (n) 117 (X = Br), DMDS, n-BuLi, THF, -78°C, 0.25 h; (o) 79 and 80; EtOCH=CHCOCl, pyridine, CH 2 Cl 2 , 0°C to r.t., 16 h; (p) conc. H 2 SO 4 , 0°C to r.t., 16 h; (r) POCl 3 , 110°C, 2.5 h to r.t., 18 h; (s) NaOMe, MeOH, reflux, 4 h; (t) (i) TMP, nBuLi, THF, -30°C, 0.25 h; (ii) 94-96; B(OiPr) 3 , THF, -78°C, 3 h; (u) 97-100, Cs 2 CO 3 , Pd(Ph 3 ) 4 , PhMe/DMF, 110°C (sealed tube), 5 h; (v) P(o-tol) 3 , Zn, Zn(CN) 2 , Pd 2 (dba) 3 , DMF, 50°C, 24 h; a Spiromorpholine (X = Z); oxalate salt required (rather than amine) for Buchwald coupling (i).
Scheme 2 Syntheses of Mannich bases 133-139 and diarylquinoline analogues 3-75
Reagents and conditions: (a) (i) HN(iPr) 2 or TMP, n-BuLi, THF, -40°C, 0.25 h; (ii) 103-132, THF, -78°C, 1.5 h; (iii) 133-139, THF, -78°C, 4 h; (b) acetophenone, CH 2 O, Me 2 N.HCl, c.HCl, EtOH, 90°C, 18 h; (c) P(o-tol) 3 , Zn, Zn(CN) 2 , Pd 2 (dba) 3 , DMF, 50°C, 5-18 h; (e) Pd/C, THF, H 2 (25 psi), r.t., 18 h; (f) 2M aq HCl, THF, r.t., 2 h; (d) K 2 CO 3 , MeOH/THF, r.t., 3 h; (g) m-CPBA, CH 2 Cl 2 , -78°C, 1 h; (h) NMO, OsO 4 , THF/H 2 O/Acetone, r.t., 3-24 h. Chemistry Methods. All solvents and reagents were used as obtained. NMR spectra were measured in a deuterated solvent on a Bruker Avance-400 spectrometer at 400 MHz for 1 H, referenced to trimethylsilane (TMS). Chemical shifts are expressed as δ units using TMS as the external standard (in NMR description, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and br = broad peak). All coupling constants (J) are reported in Hertz. High-resolution electrospray ionisation (HRESIMS) mass spectra were determined on a Bruker micrOTOF-Q II mass spectrometer. Low-resolution atmospheric pressure chemical ionisation (APCI) mass spectra were obtained for organic solutions using a ThermoFinnigan Surveyor MSQ mass spectrometer, connected to a Gilson autosampler. Chemical purities were >95% for all final compounds as assessed by reversed-phase HPLC analysis, conducted on an Agilent 1100 system, using a 150 mm x 3.2 mm Altima 5 µm reversed phase C18 column with diode array detection. Mixtures of diastereomers obtained in the final coupling reaction to give the final products in Tables 1 and 2 were separated by super-critical fluid HPLC at BioDuro LLC (Beijing) to obtain the desired RS,SR enantiomer.
Representative procedures for the syntheses of 6-bromo-, 6-cyano-and 6-morpholino-analogues of bedaquiline
Synthesis of 6-bromobedaquiline (compound 68)
Compound 97, (6-bromo-2-methoxyquinolin-3-yl)boronic acid A solution of 2,2,6,6-tetramethylpiperidine (14.4 mL, 84.8 mmol) in tetrahydrofuran (100 mL, distilled over sodium) at -78 °C was treated with n-butyllithium (33 mL, 82.5 mmol), the solution was then warmed to -20 °C for 20 minutes then cooled to -78 °C. A solution of 6-bromo-2-methoxyquinoline 1 (10.0 g, 42.0 mmol) and triisopropyl borate (20.0 mL, 87.2 mmol) in tetrahydrofuran (100 mL, distilled over sodium) was added dropwise and the orange solution was stirred for 3 hours at -78 °C, warmed to -40 °C then quenched with saturated aqueous ammonium chloride (approx. 500 mL) . The mixture was diluted with water (1 L) and the white precipitate was filtered, dried and then triturated with hexanes to give the product as a white solid (11.17 g, 94% 
Compound 118, 6-bromo-3-(2,3-dimethoxybenzyl)-2-methoxyquinoline
A stirred mixture of 97 (1.63 g, 5.79 mmol), 2,3-dimethoxybenzyl bromide (1.60 g, 6.95 mmol) and cesium carbonate (3.78 g, 11.50 mmol) in toluene (20 ml) and N,N-dimethylformamide (10 ml) was deoxygenated by bubbling nitrogen gas through it for 10 minutes.
Tetrakis(triphenylphosphine)palladium(0) (0.33 g, 0.289 mmol) was then added and the mixture was stirred under an atmosphere of nitrogen at 90 °C for 5 hours. The mixture was diluted with ethyl acetate and washed with water, then brine. The extract was dried over sodium sulfate and the solvent was removed under reduced pressure to leave the crude product as a yellow oil. The crude product was chromatographed on silica. Elution with 0-4% ethyl acetate/petroleum ether gave the product as a white solid, which crystallized from methanol as colorless microneedles (1.26 g, 56% Isomer A (high Rf 
